Last quarter (Q4 2022), Addex Therapeutics's total revenue was SFr.―, a decrease of -100.00% from the same quarter last year. In Q4, Addex Therapeutics's net income was SFr.―. See Addex Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	SFr. 830.01K	SFr. 1.42M	SFr. 2.92M	SFr. 3.61M	SFr. 2.76M	SFr. 6.04M
Cost of Revenue	-	SFr. -21.97M	-	-	-	-
Gross Profit	-	SFr. 1.42M	-	-	-	-
Operating Expense	SFr. 17.85M	SFr. 22.28M	SFr. 18.42M	SFr. 15.86M	SFr. 17.37M	SFr. 7.47M
Operating Income	SFr. -17.02M	SFr. -20.86M	SFr. -15.51M	SFr. -12.24M	SFr. -14.60M	SFr. -1.43M
Net Non Operating Interest Income Expense	SFr. -76.06K	SFr. 29.25K	SFr. -57.69K	SFr. -34.20K	SFr. -91.64K	SFr. -134.31K
Other Income Expense	SFr. -54.79K	SFr. -22.52K	SFr. 211.69K	SFr. -581.13K	SFr. -84.80K	SFr. -85.87K
Pretax Income	SFr. -17.15M	SFr. -19.53M	SFr. -15.35M	SFr. -12.86M	SFr. -14.78M	SFr. -1.64M
Tax Provision	-	-	SFr. 0.00	SFr. 0.00	SFr. 0.00	SFr. 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	SFr. -17.15M	SFr. -19.53M	SFr. -15.35M	SFr. -12.86M	SFr. -14.78M	SFr. -1.64M
Basic EPS	SFr. -2.04	SFr. -0.46	SFr. -2.70	SFr. -2.88	SFr. -3.36	SFr. -0.42
Diluted EPS	SFr. -2.04	SFr. -0.46	SFr. -2.70	SFr. -2.88	SFr. -3.36	SFr. -0.42
Basic Average Shares	SFr. 12.56M	SFr. 45.18M	SFr. 5.69M	SFr. 4.45M	SFr. 4.40M	SFr. 3.88M
Diluted Average Shares	SFr. 12.56M	-	SFr. 5.69M	SFr. 4.45M	SFr. 4.40M	SFr. 3.88M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	SFr. 10.96K	-	SFr. 16.00K	SFr. 12.00K	SFr. 0.00	SFr. 45.00K
Total Expenses	SFr. 17.85M	SFr. 313.26K	SFr. 18.42M	SFr. 15.86M	SFr. 17.37M	SFr. 7.47M
Net Income From Continuing And Discontinued Operation	SFr. -17.15M	SFr. -19.53M	SFr. -15.35M	SFr. -12.86M	SFr. -14.78M	SFr. -1.64M
Normalized Income	SFr. -17.10M	-	SFr. -15.56M	SFr. -12.28M	SFr. -14.70M	SFr. -1.56M
Interest Expense	SFr. 79.96K	-	SFr. 63.01K	SFr. 69.50K	SFr. 128.52K	SFr. 134.31K
EBIT	SFr. -17.07M	SFr. -19.56M	SFr. -15.29M	SFr. -12.79M	SFr. -14.65M	SFr. -1.51M
EBITDA	SFr. -16.83M	SFr. -19.25M	SFr. -14.94M	SFr. -12.41M	SFr. -14.32M	SFr. -1.51M

Currency in CHF

Addex Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing